18.04.2017 13:10:50

Netflix Underperform

Der Analyst Wedbush Morgan Securities Inc. hat das Kursziel für Netflix Inc. von 68 auf 73 USD angehoben, aber die Einstufung auf "Underperform" belassen.
Zusammenfassung: Netflix Inc. Underperform
Unternehmen:
Netflix Inc.
Analyst:
Wedbush Morgan Securities Inc.
Kursziel:
$ 73,00
Rating jetzt:
Underperform
Kurs*:
$ 147,25
Abst. Kursziel*:
-50,42%
Rating update:
reiterated
Kurs aktuell:
$ 194,16
Abst. Kursziel aktuell:
-62,40%
Analyst Name::
-
KGV*:
-
* Zum Zeitpunkt der Analyse

Aktienempfehlungen zu Netflix Inc.

  • Alle
  • Buy
  • Hold
  • Sell
18.10.17 Netflix Sell Société Générale Group S.A. (SG)
17.10.17 Netflix Underperform Wedbush Morgan Securities Inc.
17.10.17 Netflix overweight Cantor Fitzgerald
17.10.17 Netflix Outperform RBC Capital Markets
17.10.17 Netflix Neutral Credit Suisse Group
mehr Aktienempfehlungen

Aktien in diesem Artikel

Netflix Inc. 165,70 1,46% Netflix Inc.

Aktienempfehlungen

20.10.17 Mammoth Energy Services Outperform Imperial Capital
20.10.17 Sinclair Broadcast Grou a Buy Deutsche Bank AG
20.10.17 Nexstar Broadcasting Group Buy Deutsche Bank AG
20.10.17 Unilever Hold S&P Capital IQ
20.10.17 Unilever Hold S&P Capital IQ
20.10.17 SAP Outperform Credit Suisse Group
20.10.17 VTG buy Kepler Cheuvreux
20.10.17 Five Prime Therapeutics Outperform BMO Capital Markets
20.10.17 Chevron Market Perform BMO Capital Markets
20.10.17 HAIN CELESTIAL GROUP Market Perform BMO Capital Markets
20.10.17 Signature Ban Outperform BMO Capital Markets
20.10.17 WellCare Health Plans Outperform BMO Capital Markets
20.10.17 Universal Health Services Outperform BMO Capital Markets
20.10.17 UnitedHealth Outperform BMO Capital Markets
20.10.17 Molina Healthcare Market Perform BMO Capital Markets
20.10.17 Mednax Market Perform BMO Capital Markets
20.10.17 LifePoint Hospitals Market Perform BMO Capital Markets
20.10.17 Humana Outperform BMO Capital Markets
20.10.17 HCA Outperform BMO Capital Markets
20.10.17 Cigna Market Perform BMO Capital Markets
20.10.17 Centene Outperform BMO Capital Markets
20.10.17 Anthem Market Perform BMO Capital Markets
20.10.17 Universal Forest Products Market Perform BMO Capital Markets
20.10.17 Proofpoint Outperform Imperial Capital
20.10.17 Telefonica Equal weight Barclays Capital
20.10.17 Seattle Genetics overweight Barclays Capital
20.10.17 Regeneron Pharmaceuticals Underweight Barclays Capital
20.10.17 Celgene Buy UBS AG
20.10.17 DEUTZ kaufen DZ BANK
20.10.17 Hewlett Packard Enterprise Neutral UBS AG
20.10.17 DS a Buy Standpoint Research
20.10.17 Skechers USA Outperform Wedbush Morgan Securities Inc.
20.10.17 Novo Nordisk Equal-Weight Morgan Stanley
20.10.17 Roche Equal-Weight Morgan Stanley
20.10.17 Novartis overweight Morgan Stanley
20.10.17 Philips Lighting Equal-Weight Morgan Stanley
20.10.17 McDonalds buy Deutsche Bank AG
20.10.17 Michelin (Compagnie Générale d Etablissements Michelin SCPA) overweight Morgan Stanley
20.10.17 AstraZeneca Equal-Weight Morgan Stanley
20.10.17 ASML NV Hold S&P Capital IQ
20.10.17 Daimler Halten Independent Research GmbH
20.10.17 Ericsson (Telefon AB LMEricsson) (B) Neutral JP Morgan Chase & Co.
20.10.17 Reckitt Benckiser neutral S&P Capital IQ
20.10.17 Alphabet A (ex Google) Conviction Buy Goldman Sachs Group Inc.
20.10.17 General Electric Underweight JP Morgan Chase & Co.
20.10.17 Facebook buy Goldman Sachs Group Inc.
20.10.17 Unilever Neutral UBS AG
20.10.17 Michelin (Compagnie Générale d Etablissements Michelin SCPA) buy UBS AG
20.10.17 Hannover Rück Neutral UBS AG
20.10.17 TechnipFMC Buy Gabelli & Co